- Home
- Publications
- Publication Search
- Publication Details
Title
Blastic Plasmacytoid Dendritic Cell Neoplasm
Authors
Keywords
BPDCN, Leukemia, CD123, Bone marrow transplant, SL-401, Venetoclax
Journal
CURRENT TREATMENT OPTIONS IN ONCOLOGY
Volume 20, Issue 1, Pages -
Publisher
Springer Nature
Online
2019-02-04
DOI
10.1007/s11864-019-0605-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Blastic plasmacytoid dendritic cell neoplasm: update on therapy especially novel agents
- (2018) Shunan Wang et al. ANNALS OF HEMATOLOGY
- The advances in therapy of blastic plasmacytoid dendritic cell neoplasm
- (2018) Daniel Kerr et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Venetoclax combined with decitabine or azacitidine in treatment-naive, elderly patients with acute myeloid leukemia
- (2018) Courtney D. DiNardo et al. BLOOD
- Bortezomib as a new therapeutic approach for blastic plasmacytoid dendritic cell neoplasm
- (2017) Laure Philippe et al. HAEMATOLOGICA
- Novel treatment of blastic plasmacytoid dendritic cell neoplasm
- (2017) Solomiya Grushchak et al. MEDICINE
- Balance of Anti-CD123 Chimeric Antigen Receptor Binding Affinity and Density for the Targeting of Acute Myeloid Leukemia
- (2017) Silvia Arcangeli et al. MOLECULAR THERAPY
- Bortezomib as a new therapeutic approach for blastic plasmacytoid dendritic cell neoplasm
- (2017) Laure Philippe et al. HAEMATOLOGICA
- Clinical features and treatment outcomes of blastic plasmacytoid dendritic cell neoplasm: a single-center experience in Korea
- (2017) Hae Su Kim et al. KOREAN JOURNAL OF INTERNAL MEDICINE
- Blastic Plasmacytoid Dendritic Cell Neoplasm: Update on Molecular Biology, Diagnosis, and Therapy
- (2017) Wasif Riaz et al. Cancer Control
- Blastic plasmacytoid dendritic cell neoplasm with leukemic presentation: 10-Color flow cytometry diagnosis and HyperCVAD therapy
- (2016) Uday Deotare et al. AMERICAN JOURNAL OF HEMATOLOGY
- Blastic plasmacytoid dendritic cell neoplasm with transient response to pralatrexate
- (2016) Christian Arranto et al. ANNALS OF HEMATOLOGY
- The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia
- (2016) D. A. Arber et al. BLOOD
- Azacitidine in the treatment of blastic plasmacytoid dendritic cell neoplasm: a report of 3 cases
- (2016) Raida Khwaja et al. LEUKEMIA & LYMPHOMA
- Blastic Plasmacytoid Dendritic Cell Neoplasm Is Dependent on BCL2 and Sensitive to Venetoclax
- (2016) Joan Montero et al. Cancer Discovery
- Blastic plasmacytoid dendritic cell neoplasm frequently shows occult central nervous system involvement at diagnosis and benefits from intrathecal therapy
- (2016) Lourdes Martín-Martín et al. Oncotarget
- Treatment of blastic plasmacytoid dendritic cell neoplasm
- (2016) J. M. Sullivan et al. Hematology-American Society of Hematology Education Program
- Long-term survival following autologous and allogeneic stem cell transplantation for blastic plasmacytoid dendritic cell neoplasm
- (2015) T. Aoki et al. BLOOD
- Bendamustine for relapsed blastic plasmacytoid dendritic cell leukaemia
- (2015) Sarah Bétrian et al. HEMATOLOGICAL ONCOLOGY
- Blastic Plasmacytoid Dendritic Cell Neoplasms
- (2014) Fanny Julia et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Activity of SL-401, a targeted therapy directed to interleukin-3 receptor, in blastic plasmacytoid dendritic cell neoplasm patients
- (2014) A. E. Frankel et al. BLOOD
- Preclinical targeting of human acute myeloid leukemia and myeloablation using chimeric antigen receptor-modified T cells
- (2014) S. Gill et al. BLOOD
- Blastic plasmacytoid dendritic cell neoplasm: the first report of two cases treated by 5-Azacytidine
- (2014) Kamel Laribi et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- In vivo and in vitro sensitivity of blastic plasmacytoid dendritic cell neoplasm to SL-401, an interleukin-3 receptor targeted biologic agent
- (2014) F. Angelot-Delettre et al. HAEMATOLOGICA
- Chimeric antigen receptors against CD33/CD123 antigens efficiently target primary acute myeloid leukemia cells in vivo
- (2014) I Pizzitola et al. LEUKEMIA
- L-asparaginase with methotrexate and dexamethasone is an effective treatment combination in blastic plasmacytoid dendritic cell neoplasm
- (2013) Bérengère Gruson et al. BRITISH JOURNAL OF HAEMATOLOGY
- Blastic plasmacytoid dendritic cell neoplasm with leukemic presentation: an Italian multicenter study
- (2013) L. Pagano et al. HAEMATOLOGICA
- Stem cell transplantation can provide durable disease control in blastic plasmacytoid dendritic cell neoplasm: a retrospective study from the European Group for Blood and Marrow Transplantation
- (2012) D. Roos-Weil et al. BLOOD
- Unrelated SCT induces long-term remission in patients with blastic plasmacytoid dendritic cell neoplasm
- (2012) M Unteregger et al. BONE MARROW TRANSPLANTATION
- Sequential combination of high dose methotrexate andl-asparaginase followed by allogeneic transplant: a first-line strategy for CD4+/CD56+ hematodermic neoplasm
- (2012) Lila Gilis et al. LEUKEMIA & LYMPHOMA
- Therapeutic Effect of Lenalidomide in a Novel Xenograft Mouse Model of Human Blastic NK Cell Lymphoma/Blastic Plasmacytoid Dendritic Cell Neoplasm
- (2011) A. Agliano et al. CLINICAL CANCER RESEARCH
- 5-azacitidine prolongs overall survival in patients with myelodysplastic syndrome - a systematic review and meta-analysis
- (2009) R. Gurion et al. HAEMATOLOGICA
- Acute lymphoplasmacytoid dendritic cell (DC2) leukemia: Results from the Hellenic Dendritic Cell Leukemia Study Group
- (2009) Nikolaos J. Tsagarakis et al. LEUKEMIA RESEARCH
- CD4+ CD56+ hematodermic/plasmacytoid dendritic cell tumor with response to pralatrexate
- (2008) Justin J. Leitenberger et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started